Josée Laganière

Title: Josée Laganière: Innovator in Hematopoietic Stem Cell Research

Introduction

Josée Laganière is a notable inventor based in Canada, recognized for her contributions to the field of hematopoietic stem cell research. She holds 2 patents that focus on innovative methods for culturing and differentiating hematopoietic stem cells. Her work has significant implications for therapeutic applications, particularly in transplantation.

Latest Patents

Laganière's latest patents include methods for culturing and/or differentiating hematopoietic stem cells into progenitors. These methods involve culturing hematopoietic stem cells (HSCs) under mild hyperthermia conditions, specifically between 38°C and 40°C, in the presence of a pyrimidoindole derivative agonist. This combined approach promotes the expansion of CD34+ HSCs and their differentiation into progenitor cells, such as megakaryocytic progenitors. The patents also describe in vitro expanded cell populations of HSCs and progenitors, along with their therapeutic uses.

Career Highlights

Josée Laganière is currently associated with Hema-Quebec, where she continues her research and development in the field of stem cell therapy. Her innovative approaches have positioned her as a key figure in advancing the understanding and application of hematopoietic stem cells.

Collaborations

Laganière collaborates with Nellie Dumont, who is also involved in the research and development of hematopoietic stem cell applications. Their partnership enhances the potential for breakthroughs in this vital area of medical science.

Conclusion

Josée Laganière's work in hematopoietic stem cell research exemplifies the impact of innovative thinking in the medical field. Her patents and collaborations contribute significantly to advancements in therapeutic applications, particularly in transplantation.